David Jin
Chief Executive Officer bij AVALON GLOBOCARE CORP.
Vermogen: 494 400 $ op 31-03-2024
Profiel
David K.
Jin is currently the President, Chief Executive Officer & Director at Avalon GloboCare Corp.
He is also the President, CEO, Director & Chief Medical Officer at GenExosome Technologies, Inc. Additionally, he holds the position of Chief Executive Officer & Director at Avalon Heathcare Systems, Inc. Previously, he served as the Chief Medical Officer at Lineage Cell Therapeutics, Inc. from 2009 to 2017.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AVALON GLOBOCARE CORP.
14.05% | 29-03-2024 | 1 545 000 ( 14.05% ) | 494 400 $ | 31-03-2024 |
Actieve functies van David Jin
| Bedrijven | Functie | Begin |
|---|---|---|
| AVALON GLOBOCARE CORP. | Chief Executive Officer | 14-09-2016 |
GenExosome Technologies, Inc.
 GenExosome Technologies, Inc. MiscellaneousMiscellaneous GenExosome Technologies, Inc. Operates as an investment holding company. The company is headquartered in NV. | Chief Executive Officer | 27-09-2017 |
| Avalon Heathcare Systems, Inc. | Chief Executive Officer | - |
Eerdere bekende functies van David Jin
| Bedrijven | Functie | Einde |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| AVALON GLOBOCARE CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous GenExosome Technologies, Inc. Operates as an investment holding company. The company is headquartered in NV. | Miscellaneous |
| Avalon Heathcare Systems, Inc. |
